Changing Your Manufacturing Site Location? Read This FDA Proposal
This article was originally published in The Gray Sheet
Executive Summary
An FDA draft guidance addresses submission and inspection requirements when a company moves where device manufacturing activities take place, either within a single facility or to a completely new location, or to a contract manufacturer. It’s the latest effort by FDA to clarify what has historically been a nebulous area for manufacturers: what steps to take when making a modification to an approved device.